Brian Taylor Slingsby, Director, 10% Owner at Mineralys Therapeutics, Inc. (MLYS), bought 4,564,093 shares at $16.00 ($4.0M) on 2023-02-14, disclosed to the SEC on 2023-02-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,314,093 | $0 | 0.0% |
| 2 | $16.00 | 250,000 | $4.0M | 100.0% |
| Total | $0.88 avg | 4,564,093 | $4.0M | 100% |
| Filing → |
| MLYS | SELL | 2024-07-26 | $7.2M | — | Filing → |